Clinical trials
Active, not recruiting Small Cell Lung Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 6 |
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AbbVie | 1 |
| BeiGene | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Daiichi Sankyo | 1 |
| Guangdong Association of Clinical Trials | 1 |
| Hunan Cancer Hospital | 1 |
| Jiangsu Simcere Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 24 |
| Breast Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Carcinoma | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Carcinoma, Transitional Cell | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.